Skip to main content
SpringerLink
Log in
Book cover

Disorders of Thrombosis and Hemostasis in Pregnancy pp 31–50Cite as

Systemic Thromboembolism in Pregnancy: Thromboprophylaxis

  • Chapter
  • First Online:

  • 1014 Accesses

Abstract

Venous thromboembolism is a significant cause of maternal death in the UK, despite being a preventable condition for which clear risk factors have been identified. The introduction of routine antenatal and postnatal thromboprophylaxis for women identified by risk assessment tools has been linked to a steady reduction in the number of deaths. This chapter discusses the risk factors for the development of thromboembolism as well as the options for prophylactic intervention, and the specific clinical situations which can alter the treatment advice.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Antiplatelet Trialists’ Collaboration. Collaborative overview of randomised trials of antiplatelet therapy – III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ. 1994;308:235–46.

    Article  Google Scholar 

  2. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71–86.

    Google Scholar 

  3. Arya R, Shehata HA, Patel RK, Sahu S, Rajasingam D, Harrington K, Nelson-Piercy C, Parsons J. Internal jugular vein thrombosis following assisted conception therapy. Br J Haematol. 2001;115:153–6.

    Article  PubMed  CAS  Google Scholar 

  4. Baglin T, Barrowcliffe TW, Cohen A, Greaves M, for the British Committee for Standards in Haematology. Guidelines on the use and monitoring of heparin. Br J Haematol. 2006;133:19–34.

    Article  PubMed  CAS  Google Scholar 

  5. Bank I, Libourel EJ, Middeldorp S, van Pampus ECM, Koopman MMW, Hamulyak K, Prins MH, van der Meer J, Buller HR. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med. 2004;164(17):1932–7.

    Article  PubMed  CAS  Google Scholar 

  6. Barbier P, Jongville AP, Autre TE, Coureau C. Fetal risks with dextran during delivery. Drug Saf. 1992;7:71–3.

    Article  PubMed  CAS  Google Scholar 

  7. Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):844S–86.

    Article  PubMed  CAS  Google Scholar 

  8. Bauersachs RM, Dudenhausen J, Faridi A, Fischer T, Fung S, Geisen U, et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost. 2007;98(6):1237–45.

    PubMed  CAS  Google Scholar 

  9. Berg EM, Fasting S, Sellevold OF. Serious complications with dextran-70 despite hapten prophylaxis. Is it best avoided prior to delivery? Anaesthesia. 1991;46:1033–5.

    Article  PubMed  CAS  Google Scholar 

  10. Bezemer ID, van der Meer FJ, Eikenboom JC, Rosendaal FR, Doggen CJ. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med. 2009;169(6):610–5.

    Article  PubMed  Google Scholar 

  11. Biron-Andreani C, Schved J-F, Daures J-P. Factor V Leiden mutation and pregnancy-related venous thromboembolism. Thromb Haemost. 2006;96:14–8.

    PubMed  CAS  Google Scholar 

  12. Brady D, Raingruber B, Peterson J, Varnau W, Denman J, Resuello R, De Contreaus R, Mahnke J. The use of knee-length versus thigh-length compression stockings and sequential compression devices. Crit Care Nurs Q. 2007;30(3):255–62.

    PubMed  Google Scholar 

  13. Brill-Edwards P, Ginsberg JS, for the Recurrence Of Clot In This Pregnancy (ROCIT) Study Group. Safety of withholding antepartum heparin in women with a previous episode of venous thromboembolism. N Engl J Med. 2000;343:1439–44.

    Article  PubMed  CAS  Google Scholar 

  14. Buchtemann AS, Steins A, Volkert B, Hahn M, Klyscz T, Junger M. The effect of compression ­therapy on venous haemodynamics in pregnant women. Br J Obstet Gynaecol. 1999;106:563–9.

    Article  PubMed  CAS  Google Scholar 

  15. Conard J, Horellou MH, van Dreden P, Le Compte T, Samama M. Thrombosis in pregnancy and congenital deficiencies in AT III, protein C or protein S: study of 78 women. Thromb Haemost. 1990;63:319–20.

    PubMed  CAS  Google Scholar 

  16. Confidential Enquiry into Maternal and Child Health (CEMACH). Saving mothers’ lives: reviewing maternal deaths to make motherhood safer, 2003–05. In: Lewis G, editors. The seventh report of the confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH; 2007.

    Google Scholar 

  17. Centre for Maternal and Child Enquiries (CMACE). Saving mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–08. The eighth report on confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118(Suppl 1):1-203.

    Google Scholar 

  18. Crowther MA, Ginsberg JS, Julian J, Denburg J, Hirsh J, Douketis J, Laskin C, Fortin P, Anderson D, Kearon C, Clarke A, Geerts W, Forgie M, Green D, Costantini L, Yacura W, Wilson S, Gent M, Kovacs MJ. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N Engl J Med. 2003;349:1133–8.

    Article  PubMed  CAS  Google Scholar 

  19. Danilenko-Dixon DR, Heit JA, Silverstein MD, Yawn BP, Petterson TM, Lohse CM, Melton 3rd LJ. Risk factors for deep vein thrombosis and pulmonary embolism during pregnancy or post partum: a population-based, case–control study. Am J Obstet Gynecol. 2001;184(2):104–10.

    Article  PubMed  CAS  Google Scholar 

  20. De Stefano V, Martinelli I, Rossi E, Battaglioli T, Za T, Mannuccio Mannucci P, Leone G. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. Br J Haematol. 2006;135(3):386–91.

    Article  PubMed  Google Scholar 

  21. Dempfle CH. Minor transplacental passage of fondaparinux in vivo. N Engl J Med. 2004;350:1914–5.

    Article  PubMed  CAS  Google Scholar 

  22. Department of Health. Report of the independent expert working group on the prevention of venous thromboembolism in hospitalised patients. http://www.dh.gov.uk/dr_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_073953.pdf. Accessed Jan 2010.

  23. Dizon-Townson D, Miller C, Sibai B, Spong CY, Thom E, Wendel Jr G, Wenstrom K, Samuels P, Cotroneo MA, Moawad A, Sorokin Y, Meis P, Miodovnik M, O’Sullivan MJ, Conway D, Wapner RJ, Gabbe SG, for the National Institute of Child Health and Human Development Maternal-F et al Medicine Units Network. The relationship of the factor V Leiden mutation and pregnancy outcomes for mother and fetus. Obstet Gynecol. 2005;106(3):517–24.

    Article  PubMed  CAS  Google Scholar 

  24. Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2):CD004659. doi: 10.1002/14651858.CD004659.pub2.

  25. Finazzi G, Marchioli R, Brancaccio V, Schinco P, Wisloff F, Musial J, Baudo F, Berrettini M, Testa S, D’Angelo A, Tognoni G, Barbui T. A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost. 2005;3:848–53.

    Article  PubMed  CAS  Google Scholar 

  26. Folkeringa N, Brouwer JLP, Korteweg FJ, Veeger JGM, Erwich JJHM, van der Meer J. High risk of pregnancy-related venous thromboembolism in women with multiple thrombophilic defects. Br J Haematol. 2007;138:110–6.

    Article  PubMed  Google Scholar 

  27. Galli M, Luciani D, Bertolini G, Barbui T. Anti-beta 2-glycoprotein I, antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003;102(8):2717–23.

    Article  PubMed  CAS  Google Scholar 

  28. Geerts WH, Bergqvist D, et al. Prevention of venous thromboembolism. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381–453.

    Article  Google Scholar 

  29. Gerhardt A, Scharf RE, Zotz RB. Effect of hemostatic risk factors on the individual probability of thrombosis during pregnancy and the puerperium. Thromb Haemost. 2003;90:77–85.

    PubMed  CAS  Google Scholar 

  30. Gerhardt A, Zotz RB, Stockschlaeder M, Scharf RE. Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. Thromb Haemost. 2007;97:496–7.

    PubMed  CAS  Google Scholar 

  31. Gerhardt A, Scharf RE, Beckman MW, et al. Prothrombin and factor V mutations in women with thrombosis during pregnancy and the puerperium. N Engl J Med. 2000;342:374–80.

    Article  PubMed  CAS  Google Scholar 

  32. Glynn RJ, Ridker PM, Goldhaber SZ, Buring JE. Effect of low-dose aspirin on the occurrence of venous thromboembolism: a randomized trial. Ann Intern Med. 2007;147(8):525–33.

    PubMed  Google Scholar 

  33. Greer IA, Nelson-Piercy C. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. Blood. 2005;106:401–7.

    Article  PubMed  CAS  Google Scholar 

  34. Greer IA. Reduction in incidence of postpartum VTE following the introduction of thromboprophylaxis. Abstract presented at the International Society of Obstetric Medicine, Washington, 2008.

    Google Scholar 

  35. Health Survey for England – 2008 trend tables. Department of Health, http://www.ic.nhs.uk/statistics-and-data-collections/health-and-lifestyles-related-­surveys/health-survey-for-england. Accessed 26 Jan 2010.

  36. Heit JA, Kobbervig CE, James AH, Petterson TM, Bailey KR, Melton 3rd LJ. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study. Ann Intern Med. 2005;143:697–706.

    PubMed  Google Scholar 

  37. Horlocker TT, et al. Regional anesthesia in the ­anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med. 2003;28:172–97.

    PubMed  Google Scholar 

  38. Jacobsen AF, Skjeldestad FE, Sandet PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium – a register-based case–control study. Am J Obstet Gynecol. 2008;198:223–34.

    Article  Google Scholar 

  39. Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case – control study. J Thromb Haemost. 2008;6(6):905–12.

    Article  PubMed  CAS  Google Scholar 

  40. James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol. 2006;194(5):1311–5.

    Article  PubMed  Google Scholar 

  41. Jamieson R, Calderwood CJ, Greer IA. The effect of graduated compression stockings on blood velocity in the deep venous system of the lower limb in the postnatal period. BJOG. 2007;114:1292–4.

    Article  PubMed  CAS  Google Scholar 

  42. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:454–545.

    Article  Google Scholar 

  43. Knight M, on behalf of UKOSS. Antenatal pulmonary embolism: risk factors, management and outcomes. BJOG. 2008;115(4):453–61.

    Article  PubMed  CAS  Google Scholar 

  44. Lagrange F, Vergnes C, Brun JL, Paolucci F, Nadal T, Leng JJ, Saux MC, Banwarth B. Absence of placental transfer of pentasaccharide (fondaparinux, Arixtra®) in the dually perfused human cotyledon in vitro. Thromb Haemost. 2002;87:831–5.

    PubMed  CAS  Google Scholar 

  45. Laskin CA, Spitzer CA, Clark C, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled Hep ASA trial. J Rheumatol. 2009;36:279–87.

    Article  PubMed  CAS  Google Scholar 

  46. Larsen TB, Sorensen HT, et al. Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case–control study. Thromb Res. 2007;120(4):505–9.

    Article  PubMed  CAS  Google Scholar 

  47. Lijfering WM, Brouwer JLP, Veeger NJGM, Coppens M, Middeldorp S, Hamulyak K, Prins M, Buller HR, van der Meer J. Selective testing for thrombophilia in patients with first venous thrombosis: results from a retrospective family cohort study on absolute thrombotic risk for currently known thrombophilic defects in 2479 relatives. Blood. 2009;113(21):5314–22.

    Article  PubMed  CAS  Google Scholar 

  48. Lim W, Eikelboom JW, Ginsberg JS. Inherited thrombophilia and pregnancy associated venous thromboembolism. BMJ. 2007;334:1318–21.

    Article  PubMed  Google Scholar 

  49. Lindhoff-Last E, Kreutzenbeck H-J, Magnani HN. Treatment of 51 pregnancies with danaparoid because of heparin intolerance. Thromb Haemost. 2005;93:63–9.

    PubMed  CAS  Google Scholar 

  50. Lindqvist P, Dahlbäck B, Marŝál K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol. 1999;94:595–9.

    Article  PubMed  CAS  Google Scholar 

  51. Lindqvist PG, Svensson PJ, Marsal K, Grennert L, Luterkort M, Dahlback B. Activated protein C resistance (FV:Q506) and pregnancy. Thromb Haemost. 1999;81(4):532–7.

    PubMed  CAS  Google Scholar 

  52. Liu S, Liston RM, Joseph KS, Heaman M, Sauve R, Kramer MS, et al. Maternal mortality and severe morbidity associated with low-risk planned cesarean delivery versus planned vaginal delivery at term. CMAJ. 2007;176(4):455–60.

    Article  PubMed  Google Scholar 

  53. Lord RA, Hamilton D. Graduated compression stockings (20–30 mmHg) do not compress leg veins in the standing position. ANZ J Surg. 2004;74:581–5.

    Article  PubMed  Google Scholar 

  54. Macklon NS, Greer IA. Venous thromboembolic disease in obstetrics and gynaecology: the Scottish experience. Scott Med J. 1996;41(3):83–6.

    PubMed  CAS  Google Scholar 

  55. Marchiori A, Mosena L, Prins MH, Prandoni P. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies. Haematologica. 2007;92:1107–14.

    Article  PubMed  Google Scholar 

  56. Martinelli I, Battaglioli T, De Stefano V, Tormene D, Valdre L, Grandone E, Tosetto A, Mannucci PM, on behalf of the GIT (Gruppos Italiano Trombofilia). The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A. J Thromb Haemost. 2008;6:494–8.

    Article  PubMed  CAS  Google Scholar 

  57. Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia. Thromb Haemost. 2001;86:800–3.

    PubMed  CAS  Google Scholar 

  58. Maybury H, Waugh JJ, Gornall AS, Pavord S. There is a return to non-pregnant coagulation parameters after four not six weeks postpartum following spontaneous vaginal delivery. Obstet Med. 2008;1:92–4.

    Article  Google Scholar 

  59. Mazzolai L, Hohlfeld P, Spertini F, Hayoz D, Schapira M, Duchosal MA. Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. Blood. 2006;108:1569–70.

    Article  PubMed  CAS  Google Scholar 

  60. McColl MD, Ellison J, Reid F, et al. Prothrombin 20210GA, MTHFR C677T mutations in women with venous thromboembolism associated with pregnancy. Br J Obstet Gynaecol. 2000;107:565–9.

    Article  CAS  Google Scholar 

  61. McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, Carty MJ, Greer IA. Risk ­factors for pregnancy associated venous thromboembolism. Thromb Haemost. 1997;78(4):1183–8.

    PubMed  CAS  Google Scholar 

  62. Middeldorp S, van Hylckama Vlieg A. Does thrombophilia testing help in the clinical management of patients? Br J Haematol. 2008;143:321–35.

    Article  PubMed  Google Scholar 

  63. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RHWM, De Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost. 2006;4:295–306.

    Article  PubMed  CAS  Google Scholar 

  64. National Institute for Health and Clinical Excellence. Clinical Guideline no. 62. Antenatal Care. Routine care for the healthy pregnant woman. March 2008.

    Google Scholar 

  65. National Institute for Health and Clinical Excellence. Clinical Guideline no. 92. Venous thromboembolism: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. January 2010.

    Google Scholar 

  66. Pabinger I, Grafenhofer H, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K, Kaider A. Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood. 2002;100:1060–2.

    Article  PubMed  CAS  Google Scholar 

  67. Pabinger I, Grafenhofer H, Kaider A, Kyrle PA, Quehenberger P, Mannhalter C, Lechner K. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005;3(5):949–54.

    Article  PubMed  CAS  Google Scholar 

  68. Partsch B, Partsch H. Calf compression pressure required to achieve venous closure from supine to standing positions. J Vasc Surg. 2005;42:734–8.

    Article  PubMed  Google Scholar 

  69. Pettila V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost. 2002;87:182–6.

    PubMed  CAS  Google Scholar 

  70. Phillips S, Gallagher M, Buchan H. Use graduated compression stockings postoperatively to prevent deep vein thrombosis. BMJ. 2008;336:943–4.

    Article  PubMed  Google Scholar 

  71. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632–7.

    Article  PubMed  CAS  Google Scholar 

  72. Pulmonary embolism prevention (PEP) Trial Colla­borative Group. Prevention of pulmonary embolism and deep venous thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355:1295–302.

    Google Scholar 

  73. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997;314:253–7.

    Article  PubMed  CAS  Google Scholar 

  74. Ray JG, Chan WA. Deep vein thrombosis during pregnancy and the puerperium: a meta-analysis of the period of risk and the leg of presentation. Obstet Gynecol Surv. 1999;54(4):265–71.

    Article  PubMed  CAS  Google Scholar 

  75. Robertson B, Greaves M. Antiphospholipid syndrome: an evolving story. Blood Rev. 2006;20(4):201–12.

    Article  PubMed  CAS  Google Scholar 

  76. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GDO, Walker ID, Greaves M, Brenkel I, Regan L, Greer IA, for The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study. Br J Haematol. 2005;132(2):171–96.

    Article  Google Scholar 

  77. Robinson HE, O’Connell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol. 2005;106(6):1357–64.

    Article  PubMed  Google Scholar 

  78. Ros HS, Lichtenstein P, Bellocco R, Petersson G, Cnattingius S. Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology. 2001;12(4):456–60.

    Article  Google Scholar 

  79. Ros HS, Lichtenstein P, Bellocco R, Petersson G, Cnattingius S. Pulmonary embolism and stroke in ­relation to pregnancy: how can high-risk women be identified? Am J Obstet Gynecol. 2002;186(2):198–203.

    Article  PubMed  Google Scholar 

  80. Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood. 1995;85(5):1504–8.

    PubMed  CAS  Google Scholar 

  81. Royal College of Obstetricians and Gynaecologists. Report of the RCOG Working Party on prophylaxis against thromboembolism in gynaecology and obstetrics. London: RCOG Press;1995.

    Google Scholar 

  82. Royal College of Obstetricians and Gynaecologists. Air travel and pregnancy. Scientific Advisory Committee Opinion Paper 1. London: RCOG Press; 2008.

    Google Scholar 

  83. Royal College of Obstetricians and Gynaecologists. Green-top guideline no. 37. Thrombosis and ­embolism during pregnancy and the puerperium, Reducing the risk. 2009

    Google Scholar 

  84. Samama MM, Rached RA, Horellou M-H, Aquilanti S, Mathieux VG, Plu-Bureau G, Elalamy I, Conard J. Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation alone. Br J Haematol. 2003;123:327–34.

    Article  PubMed  CAS  Google Scholar 

  85. Sanson BJ, Lensing AWA, Prins MH, et al. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost. 1999;81:668–72.

    PubMed  CAS  Google Scholar 

  86. Simpson EL, Lawrenson RA, Nightingale AL, Farmer RDT. Venous thromboembolism in pregnancy and the puerperium: incidence and additional risk factors from a London perinatal database. BJOG. 2001;108:56–60.

    PubMed  CAS  Google Scholar 

  87. Stone S, Langford K, Nelson-Piercy C, Khamashta M, Bewley S, Hunt BJ. Antiphospholipid antibodies do not a syndrome make. Lupus. 2002;11:130–3.

    Article  PubMed  CAS  Google Scholar 

  88. Stone S, Hunt BJ, Khamashta MA, Bewley SJ, Nelson-Piercy C. Primary antiphospholipid syndrome in pregnancy: an analysis of outcome in a cohort of 33 women treated with a rigorous protocol. J Thromb Haemost. 2005;3(2):243–5.

    Article  PubMed  CAS  Google Scholar 

  89. Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs. 1990;40(4):498–530.

    Article  PubMed  CAS  Google Scholar 

  90. Vossen CY, Conard J, Fontcuberta J, Makris M, van der Meer FJM, Pabinger I, Palareti G, Preston FE, Scharrer I, Souto JC, Svensson P, Walker ID, Rosendaal FR. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J Thromb Haemost. 2005;3:459–64.

    Article  PubMed  CAS  Google Scholar 

  91. Walker ID, Greaves M, Preston FE. British Society for Haematology Guideline. Investigation and management of heritable thrombophilia. Br J Haematol. 2001;114:512–28.

    Article  CAS  Google Scholar 

  92. White RH, Chan WS, Zhou H, Ginsberg JS. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. Thromb Haemost. 2008;100(2):246–52.

    PubMed  CAS  Google Scholar 

  93. Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos A-M, Vandvik PO. VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy. Antithrombotic Therapy and prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2)(Suppl):e691S–e736S.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Acute General Medicine, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Headley Way, Headington, Oxford, OX3 9DU, UK

    Charlotte J. Frise MA, MRCP

  2. Barts and The London School of Medicine and Dentistry, Queen Mary University of London, and Barts Health NHS Trust, Charterhouse Square, EC1M 6BQ, London, UK

    Peter K. MacCallum MD, FRCP, FRCPath

  3. John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Headley Way, Headington, Oxford, OX3 9DU, UK

    Lucy H. Mackillop MA, MRCP

  4. Guy’s and St Thomas’ Foundation Trust and Imperial College Healthcare Trust, Westminster Bridge Road, London, SE1 7EH, UK

    Catherine Nelson-Piercy MA, FRCP, FRCOG

Authors
  1. Charlotte J. Frise MA, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter K. MacCallum MD, FRCP, FRCPath
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lucy H. Mackillop MA, MRCP
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Catherine Nelson-Piercy MA, FRCP, FRCOG
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Catherine Nelson-Piercy MA, FRCP, FRCOG .

Editor information

Editors and Affiliations

  1. Aberdare Gardens 36, London, NW6 3QA, United Kingdom

    Hannah Cohen

  2. Dept. Obstetrics & Gynaecology, University College Hospital, Chenies Mews 86-96, London, WC1E 6HX, United Kingdom

    Patrick O'Brien

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London

About this chapter

Cite this chapter

Frise, C.J., MacCallum, P.K., Mackillop, L.H., Nelson-Piercy, C. (2012). Systemic Thromboembolism in Pregnancy: Thromboprophylaxis. In: Cohen, H., O'Brien, P. (eds) Disorders of Thrombosis and Hemostasis in Pregnancy. Springer, London. https://doi.org/10.1007/978-1-4471-4411-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-4411-3_3

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-4410-6

  • Online ISBN: 978-1-4471-4411-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation